Acidic and basic fibroblast growth factors (FGFs) are polypeptides with potent multipotential trophic effects on central nervous system (CNS) cells: They are potent gliotrophic factors that promote the survival and proliferation of CNS glia. They are angiogenic factors that promote capillary growth and proliferation. They are potent neuronotrophic factors that promote the survival and outgrowth of a variety of CNS neurons. Recent evidence indicates that FGFs play an important role in the development, plasticity, and repair of the mammalian brain. In previous studies, we have developed methods for the assay of FGFs and their mRNA's, and for the immunolocalization of FGFs in brain. These studies have shown large changes in FGF expression during brain development and following focal injury or stroke. The proposed studies will examine the role of FGFs in the aging brain, and will test the specific hypotheses that the expression, receptors, and in vitro effects of FGFs diminish with aging. Such changes may have profound consequences on cell survival, plasticity, and repair in the aging brain. Heparin-affinity HPLC bioassay and immunoassay techniques will be used to determine changes in the relative levels of aFGF and bFGF in the aging rodent brain. Northern blotting and in situ hybridization techniques will be used to determine changes in the levels and cellular localization of FGF mRNA's. Immunohistochemical and in situ autoradiographic techniques will be used to determine changes in the relative density and cellular localization of FGF receptors. We will also directly test the in vivo cellular effects of FGFs on the mature and aging brain. Finally, we will follow-up on preliminary studies showing striking changes in FGF immunoreactivity in post-mortem human brain with Alzheimer Disease (AD). These studies will provide novel information concerning the role of FGFs in the aging brain, and may have important therapeutic implications for aging and AD.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
2R01AG008207-04
Application #
3119722
Study Section
Neurology B Subcommittee 2 (NEUB)
Project Start
1989-02-01
Project End
1994-06-30
Budget Start
1991-07-15
Budget End
1992-06-30
Support Year
4
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Finklestein, S P (1996) The potential use of neurotrophic growth factors in the treatment of cerebral ischemia. Adv Neurol 71:413-7;discussion 417-8
Speliotes, E K; Caday, C G; Do, T et al. (1996) Increased expression of basic fibroblast growth factor (bFGF) following focal cerebral infarction in the rat. Brain Res Mol Brain Res 39:31-42
Speliotes, E K; Kowall, N W; Shanti, B F et al. (1996) Myocyte-specific enhancer binding factor 2C expression in gerbil brain following global cerebral ischemia. Neuroscience 70:67-77
Kirschner, P B; Henshaw, R; Weise, J et al. (1995) Basic fibroblast growth factor protects against excitotoxicity and chemical hypoxia in both neonatal and adult rats. J Cereb Blood Flow Metab 15:619-23
Fisher, M; Meadows, M E; Do, T et al. (1995) Delayed treatment with intravenous basic fibroblast growth factor reduces infarct size following permanent focal cerebral ischemia in rats. J Cereb Blood Flow Metab 15:953-9
Rosenblatt, S; Irikura, K; Caday, C G et al. (1994) Basic fibroblast growth factor dilates rat pial arterioles. J Cereb Blood Flow Metab 14:70-4
Caday, C G; Sklar, R M; Berlove, D J et al. (1993) Polyubiquitin gene expression following cerebral ischemia. Ann N Y Acad Sci 679:188-94
Nozaki, K; Finklestein, S P; Beal, M F (1993) Basic fibroblast growth factor protects against hypoxia-ischemia and NMDA neurotoxicity in neonatal rats. J Cereb Blood Flow Metab 13:221-8
Nozaki, K; Finklestein, S P; Beal, M F (1993) Delayed administration of basic fibroblast growth factor protects against N-methyl-D-aspartate neurotoxicity in neonatal rats. Eur J Pharmacol 232:295-7
Freese, A; Finklestein, S P; DiFiglia, M (1992) Basic fibroblast growth factor protects striatal neurons in vitro from NMDA-receptor mediated excitotoxicity. Brain Res 575:351-5

Showing the most recent 10 out of 12 publications